Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Update Belgium.
May 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
5 | 6 | 7 | 8 | 9 | 10 | 11 |
12 | 13 | 14 | 15 | 16 | 17 | 18 |
19 | 20 | 21 | 22 | 23 | 24 | 25 |
26 | 27 | 28 | 29 | 30 | 31 |
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
July 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 | 31 |
Press releases published on April 24, 2025

AENO Premium Eco Slimme verwarmer met REALISTISCH VUUR Effect werd bekroond met 2 Red Dot Design Awards in 2025
LIMASSOL, CYPRUS, April 24, 2025 /EINPresswire.com/ -- AENO's nieuwe product - de AENO Premium Eco Slimme verwarmer met REALISTISCH VUUR Effect - heeft twee Red Dot Awards gewonnen in de 2025 Product Design competitie. Het apparaat werd erkend in twee …

GHSO 2025: Oman’s Flagship Green Hydrogen Summit Charts Path from Promise to Progress
More Than a Summit—A Catalyst for National Readiness and Global Integration MUSCAT, MUSCAT, OMAN, April 24, 2025 /EINPresswire.com/ -- Under the Patronage of the Ministry of Energy and Minerals Green Hydrogen Summit Oman 2025 to Launch This December …

Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients
Primary endpoint met, no drug-related serious adverse events Positive hematoma and edema volume evolution Recruitment stopped early due to positive exploratory and efficacy outcomes Preparations underway to initiate Phase 2b study Gosselies, Belgium, 24 …

Bioxodes annonce des données intermédiaires positives pour son essai de phase 2a portant sur BIOX-101 dans le traitement de l’AVC hémorragique
Le critère d’évaluation principal a été atteint, aucun événement indésirable grave associé au médicament n’a été rapporté L’évolution du volume de l’hématome et de l’œdème est favorable Le recrutement des patients a été arrêté plus tôt que prévu en raison …